(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -116.07%-1B | ---- | -76.76%5.29B | ---- | -25.74%6.25B | ---- | 294.71%22.78B | ---- | 413.83%8.42B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -89.67%-38.02M | ---- | -143.91%-54.28M | ---- | -268.34%-20.05M | ---- | 77.22%-22.25M | ---- | 81.17%-5.44M |
Dividend (income)- adjustment | ---- | 99.36%-589K | ---- | -2,894.19%-209.71M | ---- | ---91.55M | ---- | -19.58%-7M | ---- | ---- |
Investment loss (gain) | ---- | -143.66%-23.91M | ---- | 7.68%-10.64M | ---- | -72.90%-9.81M | ---- | -280.87%-11.53M | ---- | -950.93%-5.68M |
Attributable subsidiary (profit) loss | ---- | 84.30%-351.64M | ---- | 25.17%-2.93B | ---- | -46.59%-2.24B | ---- | -6,242.51%-3.91B | ---- | -5,859.68%-1.53B |
Impairment and provisions: | ---- | ---- | ---- | -68.85%3.07M | ---- | ---- | ---- | 49.36%9.86M | ---- | ---- |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | -68.85%3.07M | ---- | ---- | ---- | --9.86M | ---- | ---- |
Revaluation surplus: | ---- | 172.79%873.89M | ---- | -42.47%-576.01M | ---- | -238.54%-1.2B | ---- | 81.86%-404.31M | ---- | 259.33%866.59M |
-Other fair value changes | ---- | 172.79%873.89M | ---- | -42.47%-576.01M | ---- | -238.54%-1.2B | ---- | 81.86%-404.31M | ---- | 259.33%866.59M |
Asset sale loss (gain): | ---- | 95.75%-7.44M | ---- | -160.58%-170.04M | ---- | -291.99%-175.01M | ---- | -274.34%-65.26M | ---- | -91.41%-44.65M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | -7,531.48%-177.32M | ---- | -2,911.24%-181.89M | ---- | 525.31%2.39M | ---- | 1,229.14%6.47M |
-Loss (gain) on sale of property, machinery and equipment | ---- | -38.89%2M | ---- | -42.59%5.89M | ---- | -66.62%3.27M | ---- | 30.36%10.26M | ---- | 109,055.56%9.81M |
-Loss (gain) from selling other assets | ---- | -361.61%-9.44M | ---- | 101.78%1.39M | ---- | 105.92%3.61M | ---- | -214.85%-77.9M | ---- | -167.87%-60.92M |
Depreciation and amortization: | ---- | 72.96%582.77M | ---- | 73.43%901.55M | ---- | 43.82%336.95M | ---- | 35.49%519.84M | ---- | 42.28%234.28M |
-Depreciation | ---- | ---- | ---- | 75.73%846.27M | ---- | ---- | ---- | 36.73%481.56M | ---- | 48.57%216.66M |
-Amortization of intangible assets | ---- | 318.40%22.45M | ---- | -3.53%13.44M | ---- | -28.26%5.37M | ---- | 4.62%13.93M | ---- | -36.77%7.48M |
Financial expense | ---- | 43.55%484.31M | ---- | 109.48%765.8M | ---- | 87.61%337.37M | ---- | 46.02%365.56M | ---- | 27.58%179.82M |
Exchange Loss (gain) | ---- | 32.39%23.35M | ---- | 2,616.62%90.25M | ---- | 598.42%17.63M | ---- | 154.33%3.32M | ---- | -84.66%-3.54M |
Special items | ---- | 81.10%129.58M | ---- | -43.11%165.3M | ---- | -57.13%71.55M | ---- | 61.76%290.56M | ---- | 514.47%166.89M |
Operating profit before the change of operating capital | ---- | -79.62%668.02M | ---- | -83.27%3.27B | ---- | -60.40%3.28B | ---- | 368.59%19.54B | ---- | 492.53%8.28B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 149.74%468.2M | ---- | 131.18%2.22B | ---- | 75.43%-941.35M | ---- | -432.22%-7.12B | ---- | -1,195.69%-3.83B |
Accounts receivable (increase)decrease | ---- | -66.06%788.33M | ---- | 151.74%2.79B | ---- | 170.33%2.32B | ---- | -369.96%-5.38B | ---- | -666.80%-3.3B |
Accounts payable increase (decrease) | ---- | 70.41%-1.08B | ---- | -161.84%-4.65B | ---- | -256.95%-3.66B | ---- | 295.22%7.52B | ---- | 399.05%2.33B |
prepayments (increase)decrease | ---- | 448.41%2.32B | ---- | -70.61%-1.21B | ---- | -65.47%-666.94M | ---- | -386.67%-706.48M | ---- | -130.23%-403.06M |
Cash from business operations | ---- | 860.18%3.16B | ---- | -82.51%2.42B | ---- | -89.28%329.55M | ---- | 302.13%13.85B | ---- | 219.20%3.07B |
Other taxs | ---- | 87.55%-320.85M | ---- | -402.93%-2.61B | ---- | -1,267.73%-2.58B | ---- | -420.98%-518.39M | ---- | -195.70%-188.41M |
Special items of business | ---- | 347.66%1.1B | ---- | 139.43%331.76M | ---- | 43.81%-443.8M | ---- | -16.16%-841.48M | ---- | -193.41%-789.78M |
Adjustment items of business operations | 399.90%4.11B | ---- | 103.75%118.86M | ---- | -117.20%-1.37B | ---- | -379.24%-3.17B | ---- | 757.77%7.96B | ---- |
Net cash from operations | 399.90%4.11B | 246.50%3.94B | 103.75%118.86M | -98.83%146.48M | -117.20%-1.37B | -228.36%-2.69B | -379.24%-3.17B | 376.67%12.49B | 757.77%7.96B | 232.59%2.1B |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | --10.78M | ---- | -92.14%2.01M | ---- | ---- | ---- | -53.86%25.59M | ---- | 14.62%19.62M |
Dividend received - investment | -93.95%104.92M | -97.56%38.96M | ---- | 38.50%2.53B | 72.07%1.73B | 76.48%1.59B | 225,806.80%832.8M | 31,081.30%1.83B | 3,674.87%1.01B | 50,052.92%903.25M |
Restricted cash (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%313.57M | ---- | --313.57M |
Loan receivable (increase) decrease | ---- | 84.47%-40M | ---- | -170.14%-540.81M | ---- | -259.27%-257.5M | ---- | -142.51%-200.19M | ---- | 186.72%161.68M |
Sale of fixed assets | 177.64%7.15M | 800.76%7.12M | --158.2K | -83.30%4.64M | -40.53%2.58M | -79.06%790K | ---- | 1,078.94%27.76M | 1,763.04%4.33M | 19,757.89%3.77M |
Purchase of fixed assets | -23.25%-7.05B | 6.49%-4.38B | 44.40%-957.49M | -74.59%-7.4B | -129.55%-5.72B | -167.86%-4.68B | -392.51%-1.72B | -39.46%-4.24B | -77.83%-2.49B | -51.02%-1.75B |
Purchase of intangible assets | ---- | 70.36%-182.83M | ---- | -75.22%-1.25B | ---- | 4.39%-616.74M | ---- | -90.00%-711.76M | ---- | -294.80%-645.09M |
Sale of subsidiaries | ---- | ---- | ---- | --203.19M | --3.56M | --203.74M | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | 62.93%-678.84M | -5.82%-679.48M | 113.67%56.04M | 77.78%-1.93B | -24.78%-1.83B | 56.25%-642.12M | 62.21%-409.97M | -373.59%-8.7B | -2,979.30%-1.47B | ---1.47B |
Recovery of cash from investments | 122.95%1.81B | -20.86%542.65M | 12,007.73%208.9M | -47.50%614.75M | -28.54%811.81M | 664.87%685.73M | --1.73M | -9.56%1.17B | -42.21%1.14B | -94.88%89.65M |
Cash on investment | -20.95%-1.56B | -28.01%-1.33B | -52.12%-1.36B | 50.25%-2.42B | 63.41%-1.29B | 45.70%-1.04B | -0.13%-890.82M | -93.77%-4.86B | -135.47%-3.52B | -14.85%-1.92B |
Other items in the investment business | 99.47%-4.75M | ---- | 91.35%-31.94M | ---- | -2,816.19%-891.43M | ---- | 0.40%-369.13M | -48.30%33.35M | 101.89%32.82M | ---- |
Net cash from investment operations | -2.65%-7.37B | -26.46%-6.01B | 18.70%-2.08B | 33.50%-10.18B | -35.45%-7.18B | -10.97%-4.76B | 5.01%-2.56B | -147.94%-15.31B | -97.50%-5.3B | -205.22%-4.29B |
Net cash before financing | 61.83%-3.26B | 72.19%-2.07B | 65.76%-1.96B | -255.69%-10.04B | -421.32%-8.55B | -240.24%-7.45B | -267.66%-5.73B | 20.64%-2.82B | 251.54%2.66B | -182.91%-2.19B |
Cash flow from financing activities | ||||||||||
New borrowing | -14.55%12.14B | -34.26%7.77B | -25.61%5.01B | 80.16%19.06B | 93.30%14.2B | 98.94%11.82B | 404.32%6.73B | 60.04%10.58B | 54.00%7.35B | 89.47%5.94B |
Refund | -128.72%-8.26B | -94.59%-5.71B | -90.17%-3.22B | -97.87%-6.61B | -25.17%-3.61B | -23.71%-2.93B | -53.01%-1.7B | 16.50%-3.34B | -34.08%-2.88B | -64.18%-2.37B |
Interest paid - financing | ---- | -53.25%-312.79M | ---- | -113.89%-530.45M | ---- | -88.22%-204.1M | ---- | -38.00%-248M | ---- | -36.13%-108.44M |
Dividends paid - financing | 4.79%-2.23B | ---- | -120.24%-230.83M | -366.99%-2.02B | -275.64%-2.35B | ---- | -59.60%-104.81M | -3.63%-431.95M | -16.14%-624.92M | ---347.47M |
Absorb investment income | -94.15%30M | -94.00%25M | -94.52%20M | 270.32%418.46M | 4,614.82%512.97M | 4,665.25%416.96M | 9,305.00%364.91M | -90.40%113M | -99.78%10.88M | -86.50%8.75M |
Issuance expenses and redemption of securities expenses | ---- | -135.64%-196.88M | ---- | -62.96%-216.99M | ---- | ---83.55M | ---- | -465.99%-133.15M | ---- | ---- |
Pledged bank deposit (increase) decrease | ---- | 112.68%30.08M | ---- | 223.40%493.3M | ---- | 12.71%-237.28M | ---- | -4,465.03%-399.76M | ---- | -186.12%-271.81M |
Other items of the financing business | -12.74%-707.19M | -59.43%-562.93M | 100.00%-30.14K | -241.83%-378.17M | -785.13%-627.3M | -1,781.45%-353.09M | -5,315.13%-717.45M | 613.84%266.63M | 457.44%91.56M | ---18.77M |
Net cash from financing operations | -88.11%966.47M | -87.73%1.03B | -65.64%1.57B | 59.53%10.22B | 106.32%8.13B | 197.80%8.41B | 2,459.49%4.58B | -10.18%6.4B | -43.79%3.94B | -49.48%2.83B |
Effect of rate | -179.33%-52M | -93.85%4.65M | -38.75%14.74M | -84.51%39.7M | -86.63%65.55M | -49.30%75.49M | 123.11%24.07M | 598.15%256.32M | 568.61%490.16M | 570.72%148.92M |
Net Cash | -450.46%-2.3B | -207.22%-1.04B | 66.27%-386.93M | -94.95%181.01M | -106.32%-417.06M | 52.02%968.35M | 16.80%-1.15B | 0.21%3.58B | 25.61%6.6B | -86.78%637M |
Begining period cash | 2.43%9.29B | 2.43%9.29B | 2.43%9.29B | 73.36%9.07B | 73.36%9.07B | 73.36%9.07B | 73.36%9.07B | 206.13%5.23B | 206.13%5.23B | 206.13%5.23B |
Cash at the end | -20.36%6.95B | -18.35%8.26B | 12.22%8.92B | 2.43%9.29B | -29.23%8.72B | 68.07%10.12B | 111.96%7.95B | 73.36%9.07B | 79.66%12.32B | -7.35%6.02B |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | -3.64%9.55B | ---- | ---- | ---- | 56.57%9.91B | ---- | ---- |
Cash and cash equivalent balance | ---- | ---- | ---- | -3.64%9.55B | ---- | ---- | ---- | 56.57%9.91B | ---- | ---- |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data